Jb. Sebens et al., DIFFERENTIAL FOS-PROTEIN INDUCTION IN RAT FOREBRAIN REGIONS AFTER ACUTE AND LONG-TERM HALOPERIDOL AND CLOZAPINE TREATMENT, European journal of pharmacology, 273(1-2), 1995, pp. 175-182
Both acute and long-term effects of haloperidol and clozapine on Fos-l
ike immunoreactive nuclei in several rat forebrain areas were quantifi
ed. Rats were treated with saline (1 ml/kg.day, control), haloperidol
(1 mg/kg.day) and clozapine (20 mg/kg.day) i.p. for 21 days. Two hours
before perfusion fixation a single (acute treatment) or last (long-te
rm treatment) dose of the drug was given. Drug-induced catalepsy and g
ain in body weight were also measured. A single dose of haloperidol pr
oduced large increases in Fos-like immunoreactive nuclei in the striat
um, the nucleus accumbens and central amygdala. Following long-term tr
eatment these increases were reduced in all nuclei studied, except the
lateral septum. Acute clozapine treatment had slight (if any) effects
on the number of Fos-like immunoreactivity-expressing nuclei in the s
triatum, but the increases in the nucleus accumbens, the lateral septu
m, the paraventricular and supraoptic nuclei of the hypothalamus and t
he central amygdala were substantial. Long-term clozapine treatment re
duced the acute response significantly in all the areas except the nuc
leus accumbens. Both haloperidol and clozapine treatment reduced the w
eight gain of the rats. Haloperidol, but not clozapine, induced catale
psy that remained maximal during the long-term haloperidol treatment.
These results indicate that in most brain areas high Fos-protein level
s are not necessary to maintain antipsychotic activity or side-effects
. The persisting effect of clozapine in the nucleus accumbens may be o
f significance to the efficacy of this drug in treatment-refractory sc
hizophrenia.